IL-22 promotes Fas expression in oligodendrocytes and inhibits FOXP3 expression in T cells by activating the NF-κB pathway in multiple sclerosis.
2017
Abstract Multiple sclerosis (MS) is characterized by an increase in
interleukin-22and Fas, and a decrease in
FOXP3, among other factors. In this study, we examined patients with MS and healthy control subjects and used the
experimental autoimmune encephalomyelitis(EAE) animal model to identify the effects of IL-22 on
oligodendrocytesand T cells in MS development. In MS, the expression of Fas in
oligodendrocytesand IL-22 in CD4 +
CCR4+ CCR6 +
CCR10+ T cells was enhanced. Ikaros and
FOXP3were both decreased in T cells. Depending on exogenous IL-22, Fas increased the phosphorylation of mitogen- and stress-activated protein kinase 1 and activated the nuclear factor-κB pathway in
oligodendrocytes, leading to an increase in Fas and
oligodendrocyteapoptosis. IL-22 decreased
FOXP3expression by activating NF-κB, and it further inhibited PTEN and Ikaros expression. Tregs reversed the functions of IL-22. Taken together, these findings help to elucidate the mechanisms of IL-22 in MS development.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
36
References
14
Citations
NaN
KQI